Does time of CCI measurement affect the evaluation of platelet transfusion effectiveness?

被引:5
作者
Matsui, Reina [1 ]
Hagino, Takeshi [2 ]
Tsuno, Nelson Hirokazu [3 ]
Ohtani, Hideo [1 ]
Azuma, Fumihiro [3 ]
Matsuhashi, Mika [3 ]
Saito, Makoto [4 ]
Kobayashi, Maya [2 ]
Saga, Reina [2 ]
Hidai, Hiroko [2 ]
Tsutsumi, Hisashi [1 ]
Akiyama, Hideki [2 ]
Motomura, Sayuri [2 ]
机构
[1] Tokyo Metropolitan Hlth & Med Treatment Corp, Tama Hokubu Med Ctr, Dept Lab Med, Tokyo, Japan
[2] Tokyo Metropolitan Hlth & Med Treatment Corp, Tama Hokubu Med Ctr, Dept Hematol, 1-7-1 Aobachou, Higashimurayama, Tokyo 1898511, Japan
[3] Japanese Red Cross Kanto Koshinetsu Block Blood C, Tokyo, Japan
[4] Komagome Hosp, Clin Res Support Ctr, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
关键词
Platelet transfusion refractoriness; The corrected count increment (CCI); ABO-compatible platelet concentrate; Single donor apheresis platelets; Japanese guideline for the appropriate use of; blood products (revised in 2017); REFRACTORINESS; ALLOIMMUNIZATION;
D O I
10.1016/j.transci.2021.103123
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The measurement of corrected count increment at 1-h post-transfusion (CCI-1 h) of platelet concentrate (PC) transfusion is recommended, but in the revised Japanese Guideline (2017) it was changed to "after 10-min to 1h", following the revision of the guidelines from Western countries. Here, we aimed to investigate on the feasibility to apply the CCI measured at 10-min or 30-min post-transfusion as the surrogate of CCI-1 h. Peripheral blood was collected at 10-min, 30-min and 1-h post-transfusion of PC and the effectiveness of the transfusion was analyzed based on the CCI. In the period from December 2017 to February 2020, 8 patients, who received multiple PC transfusion (total 208) at our institution, were analyzed. We performed the univariate analyses to examine the relationship between CCI value and the categorical variables, p-value <0.1 was obtained for gender (p = 2.91 & times; 10-19), fever after transfusion (p = 0.0163). The qualitative variables, namely measurement time (p = 0.0553), also showed p-value <0.1. Using these factors as covariates in the mixed effect model, we found that the measurement time (p = 0.0007) had a significant effect on the CCI value when looking at fixed effects. Although there is a tendency for decreased CCI values with time progression, the slope of the change in the mixed model was -0.00307, indicating that the CCI difference among the 3 measurements was small. Here we provide evidence that CCI measured at 10-min and 30-min post-transfusion give results comparable to those measured at 1-h post-transfusion, under the Japanese practice of platelet transfusion, which relies on 100 % single-donor apheresis PC, and ABO-identical whenever possible.
引用
收藏
页数:5
相关论文
共 13 条
[1]   EFFECT OF ANTICOAGULANT AND ABO INCOMPATIBILITY ON RECOVERY OF TRANSFUSED HUMAN PLATELETS [J].
ASTER, RH .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1965, 26 (06) :732-&
[2]  
BISHOP JF, 1988, BLOOD, V71, P383
[3]   Evaluation of platelet transfusion triggers in a tertiary-care hospital [J].
Cameron, Bruce ;
Rock, Gail ;
Olberg, Bernard ;
Neurath, Doris .
TRANSFUSION, 2007, 47 (02) :206-211
[4]   Where did platelets go in 2012? A survey of platelet transfusion practice in the North of England [J].
Charlton, A. ;
Wallis, J. ;
Robertson, J. ;
Watson, D. ;
Iqbal, A. ;
Tinegate, H. .
TRANSFUSION MEDICINE, 2014, 24 (04) :213-218
[5]   IMMEDIATE EFFECTS OF INTRAVENOUS ENDOTOXIN ON SEROTONIN CONCENTRATIONS AND BLOOD PLATELETS [J].
DAVIS, RB ;
MEEKER, WR ;
MCQUARRIE, DG .
CIRCULATION RESEARCH, 1960, 8 (01) :234-239
[6]   RELATIVE IMPORTANCE OF IMMUNE AND NONIMMUNE CAUSES OF PLATELET REFRACTORINESS [J].
DOUGHTY, HA ;
MURPHY, MF ;
METCALFE, P ;
ROHATINER, AZS ;
LISTER, TA ;
WATERS, AH .
VOX SANGUINIS, 1994, 66 (03) :200-205
[7]   Platelet utilization and the transfusion trigger: a prospective analysis [J].
Greeno, Edward ;
McCullough, Jeffrey ;
Weisdorf, Daniel .
TRANSFUSION, 2007, 47 (02) :201-205
[8]   Investigation of the freely available easy-to-use software 'EZR' for medical statistics [J].
Kanda, Y. .
BONE MARROW TRANSPLANTATION, 2013, 48 (03) :452-458
[9]  
McFarland J, 1997, NEW ENGL J MED, V337, P1861
[10]  
NEAME PB, 1980, BLOOD, V56, P88